PGA Tour revises drug testing program

Beginning in October when the 2017-18 season begins, the PGA Tour will begin blood testing as part of its revised anti-doping program.

The Tour also is updating its list of banned substances to include those currently forbidden by the World AntiDoping Agency (WADA).

Further, any suspensions of players abusing any banned substance will be announced publicly for the first time.

“We believe that these changes to our program are prudent in that they further our objectives of protecting the well-being of our members and better substantiate the integrity of golf as a clean sport,” Tour commissioner Jay Monahan said in a statement released Tuesday.

Urine testing can detect many banned substances but it cannot detect human growth hormone.